The FDA Just Approved the New Drug Application for Migalastat, a Treatment For Fabry Disease
source: pixabay.com

The FDA Just Approved the New Drug Application for Migalastat, a Treatment For Fabry Disease

According to an article from globenewswire.com, the pharmaceutical company Amicus Therapeutics announced that the Food and Drug Administration (FDA) has the company's New Drug Application for migalastat with filing for…

Continue Reading The FDA Just Approved the New Drug Application for Migalastat, a Treatment For Fabry Disease
Potential Fabry Disease Treatment is Granted Orphan Drug Status
source: pixabay.com

Potential Fabry Disease Treatment is Granted Orphan Drug Status

The pharmaceutical company Protalix Biotherapeutics, Inc. announced that a drug currently in development called PRX-102 has been granted orphan drug status by the European Commission. The treatment is being developed…

Continue Reading Potential Fabry Disease Treatment is Granted Orphan Drug Status
First Approved Fabry Treatment Option for Canadians in Nearly Fifteen Years
Source: Pixabay

First Approved Fabry Treatment Option for Canadians in Nearly Fifteen Years

Amicus Therapeutics is an American therapeutics company based in Cranbury, New Jersey. They're new groundbreaking treatment announcement, however, has very little to do with America, or even New Jersey for that…

Continue Reading First Approved Fabry Treatment Option for Canadians in Nearly Fifteen Years
Around the U.S. in Seven Days: NASCAR Driver Fundraises for Fabry, Other Rare Diseases
Source: www.pixabay.com

Around the U.S. in Seven Days: NASCAR Driver Fundraises for Fabry, Other Rare Diseases

Earlier this year, Kyle Petty made his way across the country for his annual fundraiser appropriately called "Ride Across America." While Petty, a famous NASCAR racer, says one of his…

Continue Reading Around the U.S. in Seven Days: NASCAR Driver Fundraises for Fabry, Other Rare Diseases
Close Menu